SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

デジタルセラピューティクスとウェルネス　2022-2026年

出版：Juniper Research（ジュニパーリサーチ）　出版年月：2022年3月

DIGITAL THERAPEUTICS & WELLNESS: KEY TRENDS, BUSINESS MODELS & MARKET FORECASTS 2022-2026
デジタルセラピューティクスとウェルネス：重要動向、ビジネスモデル、市場予測　2022-2026年

価格 (※)GBP3,750
種別英文調査報告書

※部分購入も可能です。詳細はこちらをご覧ください。

レポート目次　　お問合せ・ご注文　　価格・納期について

無料サンプル

ジュニパーリサーチ「デジタルセラピューティクスとウェルネス：重要動向、ビジネスモデル、市場予測　2022-2026年 – DIGITAL THERAPEUTICS & WELLNESS: KEY TRENDS, BUSINESS MODELS & MARKET FORECASTS 2022-2026」は世界のデジタルセラピューティクス（DTx）とウェルネス市場を調査し、詳細な分析・予測結果を提供しています。

このレポートはデジタルセラピューティクス（DTx）とウェルネス市場を方向付ける促進要因、発展、課題について考察し、主要セグメントについて詳細な分析を行っています。

主要セグメント

  • 喘息およびCOPD治療
  • CVDおよび高血圧症治療
  • 糖尿病治療
  • 理学療法
  • 禁煙
  • 体重管理治療
  • コンシューマ向けデジタルウェルネスアプリ
  • 企業向けデジタルウェルネスプログラム

主な掲載内容

  • エコシステム分析：下記をはじめとした主要ステークホルダーを対象としたDTxおよびウェルネスのバリューチェーンに関する鋭い分析
    • 製品ベンダ
    • システムインテグレータ
    • 規制機関
    • 臨床医と従業員
    • 医療保険会社
  • ビジネスモデル
  • Juniper Researchの競合スコアボード
  • 産業予測：主要30ヶ国毎の市場データ

当レポートは下記疑問への回答につながる情報を提供しています。

  • DTxとウェルネス市場において最も有望かつ新しい動向は何か？
  • DTxとウェルネス市場を促進するビジネスモデルには何があるか？
  • ステークホルダーが直面している最も大きい課題は何か？
  • DTxとウェルネス市場をリード、挑戦、混乱させてるのはどのベンダか？
  • DTxとウェルネス市場の価値は今後5年間でどのように伸びるか？

当レポートは下記オプション毎に価格が設定されています。

レポート構成＆価格表

(1) 動向＆戦略調査
  • 市場動向＆戦略レポート（PDF）
    Market trends & strategies report
GBP 1,990
  • 競合スコアボードレポート（PDF）
    Competitor leaderboard report
GBP 1,990
(2) 市場規模＆予測GBP 2,990
    • 市場データ＆予測レポート（PDF)
      Market Data & Forecasts PDF Report
    • インタラクティブ予測データ（Excel）
      Interactive Forecast Excel Data
    • 最新データへの12ヶ月アクセス
      harvest market data platform (12 months’ online access)
フルセット (1と2の全てをご購入の場合）GBP3,750

各レポートの目次はこちらよりご依頼ください

Juniper Research’s latest Digital Therapeutics & Wellness research report offers in-depth assessment of this fast-changing market; providing critical insights into the key stakeholders powering the digital therapeutics and wellness ecosystem, as well as appraising the business models driving growth globally. The report also provides an in-depth analysis of the drivers, developments, and challenges shaping the market, plus detailed analysis and forecasts for the following key segments:

  • Asthma & COPD Therapeutics
  • CVD & Hypertension Therapeutics
  • Diabetes Therapeutics
  • Physical Therapy Therapeutics
  • Smoking Cessation Therapeutics
  • Weight Management Therapeutics
  • Consumer Digital Wellness Apps
  • Corporate Digital Wellness Programmes

The research also contains a 15-vendor Juniper Research Competitor Leaderboard, which positions key vendors in the digital therapeutics space on their relative strengths, accompanied by individual profiles appraising each vendor’s respective offerings, and providing personalised recommendations for success.

This research suite includes:

  • Market Strategies & Trends (PDF)
  • Market Data & Forecasting (PDF)
  • Competitor Leaderboard (PDF)
  • 12 Months’ Access to harvest Online Data Platform

KEY FEATURES

  • Ecosystem Analysis: An insightful analysis of the digital therapeutics and wellness value chains; covering key stakeholders including:
    • Product Vendors
    • Systems Integrators
    • Regulatory Bodies
    • Clinicians & Employers
    • Health Insurers
  • Business Models: A detailed appraisal of monetisation practices used by stakeholders within the digital therapeutics and wellness value chains, in particular:
    • How these models are evolving with the maturation of the digital therapeutics and wellness market.
    • What challenges stakeholders must overcome if widespread adoption of these technologies is to be achieved.
  • Juniper Research Competitor Leaderboard: 15 players offering digital therapeutics compared, scored, and positioned on the Juniper Research Competitor Leaderboard, including:
    • 2Morrow
    • Big Health
    • Click Therapeutics
    • Happify Health
    • Headspace Health
    • Kaia Health
    • Livongo
    • my mhealth
    • Omada Health
    • Pear Therapeutics
    • Sidekick Health
    • Vida Health
    • Voluntis
    • Wise Therapeutics
    • Welldoc
  • Benchmark Industry Forecasts: Our forecasts for the current and future position of the digital therapeutics and wellness market, including the number of people using digital therapeutics, number of consumer wellness apps in use, number of employees enrolled in corporate wellness schemes, and total revenue, split by 30 countries:
    • Argentina
    • Australia
    • Brazil
    • Canada
    • China
    • Colombia
    • Denmark
    • India
    • Indonesia
    • Finland
    • France
    • Germany
    • Italy
    • Japan
    • Mexico
    • Netherlands
    • Nigeria
    • Norway
    • Pakistan
    • Poland
    • Portugal
    • Russia
    • Saudi Arabia
    • South Africa
    • Singapore
    • South Korea
    • Spain
    • Sweden
    • UK
    • US

KEY QUESTIONS

  1. What are the most promising emerging trends within the digital therapeutics and wellness space?
  2. What are the business models driving the digital therapeutics and wellness market?
  3. What are the biggest challenges facing stakeholders within the digital therapeutics and wellness space?
  4. Which vendors are leading, challenging, and disrupting the digital therapeutics market?
  5. How will the value of the digital therapeutics and wellness market grow over the next 5 years?

COMPANIES REFERENCED

Interviewed: Sidekick Health, Voluntis, Wise Therapeutics.

Included in Juniper Research Competitor Leaderboard: 2Morrow, Big Health, Click Therapeutics, Happify Health, Headspace Health, Kaia Health, Livongo, my mhealth, Omada Health, Pear Therapeutics, Sidekick Health, Vida Health, Voluntis, Wise Therapeutics, Welldoc.

Mentioned: 3M, AbbVie, Accelmed, Adobe, American Diabetes Association, American Eagle, AptarGroup, ArrowMark Partners, Asabys Partners, AstraZeneca, AXA Venture Partners, Balderton Capital, Biocon Biologics, Blue Cross Blue Shield, Blue Shield of California, Boehringer Ingelheim, Boeing, Boston Medical, Bournemouth University , Bristol Myers Squibb, Caritas District of Columbia, Centene, Chiesi Group, Cigna, Cisco, Cleveland Clinic, Copado, Costco, Crossroads, CVS Health, Deerfield Management Company , Delta Air Lines, Dexcom, eBay, Eisai, Eurazeo, FDA, Fred Hutchinson Cancer Research Center, Frumtak Ventures, General Atlantic, GuideWell, H.I.G. BioHealth , Harvard School of Public Health, Higi, Home Depot, Humana, Innovate UK, ION Crossover Partners, JAMA Internal Medicine, Johnson & Johnson, Kaiser Permanente, LifeScan, Lilly, Magellan Health, Marvin, Medicaid, Merck Global Health Innovation Fund Ventures, Microsoft, NASDAQ, National Committee for Quality Assurance, NHS, Novartis, Novator , Oklahoma Health Care Authority, Omega Capital Partners, Optum Ventures, Orcha, Otsuka, Point32Health, Samsung, Sanofi, SoftBank, Solera Health, Stanford School of Medicine, Starbucks, Teladoc Health, The Hartford, Thimble Point Acquisition Corp, University of Maryland’s Center for Health Information and Decision System, University of Oxford, ViacomCBS, Visa, Vitality, Vodafone, Wellington Partners, WPS Health Insurance, WRF Capital, youturn.

DATA & INTERACTIVE FORECAST

Juniper Research’s Digital Therapeutics & Wellness forecast suite includes:

  • 5-year benchmark forecasts for:
    • Number of People Using Digital Therapeutics, Split by Region/Country
    • Number of People Using Digital Therapeutics, Split by Addressed Condition
    • Number of People Using Digital Therapeutics, Split by Payer
    • Total Digital Therapeutics Revenue, Split by Region/Country
    • Total Digital Therapeutics Revenue, Split by Addressed Condition
    • Total Digital Therapeutics Revenue, Split by Payer
    • Number of People Using Digital Wellness Products, Split by Region/Country
    • Number of People Using Digital Wellness Products, Split by Market Segment
    • Total Digital Wellness Revenue, Split by Region/Country
    • Total Digital Wellness Revenue, Split by Market Segment
  • Data splits for 8 key global regions and 30 select countries:
    • Argentina
    • Australia
    • Brazil
    • Canada
    • China
    • Colombia
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Indonesia
    • Italy
    • Japan
    • Mexico
    • Netherlands
    • Nigeria
    • Norway
    • Pakistan
    • Poland
    • Portugal
    • Russia
    • Saudi Arabia
    • Singapore
    • South Africa
    • South Korea
    • Spain
    • Sweden
    • UK
    • US
  • Access to the full set of forecast data of 220 tables and over 96,000 datapoints.
  • Interactive Excel Scenario tool allowing users to manipulate Juniper Research’s data for 4 different metrics.

Juniper Research’s highly granular Interactive Excels enable clients to manipulate Juniper Research’s forecast data and charts to test their own assumptions using the interactive scenario tool and comparing select markets side-by-side in customised charts and tables. IFxls greatly increase clients’ ability to both understand a particular market and to integrate their own views into the model.

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    医療・医薬の最新記事8件